<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease - Bizzarro, M - 2014 | Cochrane Library</title> <meta content="Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease - Bizzarro, M - 2014 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005055.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease - Bizzarro, M - 2014 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005055.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD005055.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease" name="citation_title"/> <meta content="Matthew Bizzarro" name="citation_author"/> <meta content="Yale University School of Medicine" name="citation_author_institution"/> <meta content="matthew.bizzarro@yale.edu" name="citation_author_email"/> <meta content="Ian Gross" name="citation_author"/> <meta content="Yale University School of Medicine" name="citation_author_institution"/> <meta content="Fabiano T Barbosa" name="citation_author"/> <meta content="Hospital Geral do Estado Professor Osvaldo BrandÃ£o Vilela" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="7" name="citation_issue"/> <meta content="10.1002/14651858.CD005055.pub3" name="citation_doi"/> <meta content="2014" name="citation_date"/> <meta content="2014/07/03" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005055.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005055.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005055.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Administration, Inhalation; Heart Defects, Congenital [*surgery]; Heart Diseases [congenital, surgery]; Hypertension, Pulmonary [*drug therapy, mortality]; Nitric Oxide [administration &amp; dosage, *therapeutic use]; Postoperative Complications [*drug therapy, mortality]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005055.pub3&amp;doi=10.1002/14651858.CD005055.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005055.pub3&amp;doi=10.1002/14651858.CD005055.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005055.pub3&amp;doi=10.1002/14651858.CD005055.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005055.pub3&amp;doi=10.1002/14651858.CD005055.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005055.pub3&amp;doi=10.1002/14651858.CD005055.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005055.pub3&amp;doi=10.1002/14651858.CD005055.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005055.pub3&amp;doi=10.1002/14651858.CD005055.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005055.pub3&amp;doi=10.1002/14651858.CD005055.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005055.pub3&amp;doi=10.1002/14651858.CD005055.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005055.pub3&amp;doi=10.1002/14651858.CD005055.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005055.pub3&amp;doi=10.1002/14651858.CD005055.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005055.pub3&amp;doi=10.1002/14651858.CD005055.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005055.pub3&amp;doi=10.1002/14651858.CD005055.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005055.pub3&amp;doi=10.1002/14651858.CD005055.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005055.pub3&amp;doi=10.1002/14651858.CD005055.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005055.pub3&amp;doi=10.1002/14651858.CD005055.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005055.pub3&amp;doi=10.1002/14651858.CD005055.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005055.pub3&amp;doi=10.1002/14651858.CD005055.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005055.pub3&amp;doi=10.1002/14651858.CD005055.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005055.pub3&amp;doi=10.1002/14651858.CD005055.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005055.pub3&amp;doi=10.1002/14651858.CD005055.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005055.pub3&amp;doi=10.1002/14651858.CD005055.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005055.pub3&amp;doi=10.1002/14651858.CD005055.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="jiwTpTuf";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD005055\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD005055\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005055\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005055\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ms","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD005055.pub3",title:"Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease",firstPublishedDate:"Jul 3, 2014 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Anaesthesia Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jiwTpTuf&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005055.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005055.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> EspaÃ±ol </option> <option class="content-language-option" data-languagecode="fa" value="fa"> ÙØ§Ø±Ø³Û </option> <option class="content-language-option" data-languagecode="fr" value="fr"> FranÃ§ais </option> <option class="content-language-option" data-languagecode="hi" value="hi"> à¤¹à¤¿à¤¨à¥à¤¦à¥ </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> æ¥æ¬èª </option> <option class="content-language-option" data-languagecode="ko" value="ko"> íêµ­ì´ </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> PortuguÃªs </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Ð ÑÑÑÐºÐ¸Ð¹ </option> <option class="content-language-option" data-languagecode="ro" value="ro"> RomÃ¢nÄ </option> <option class="content-language-option" data-languagecode="ta" value="ta"> à®¤à®®à®¿à®´à¯ </option> <option class="content-language-option" data-languagecode="th" value="th"> à¸ à¸²à¸©à¸²à¹à¸à¸¢ </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> ç¹é«ä¸­æ </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> ç®ä½ä¸­æ </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD005055.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD005055.pub3/full/es"> EspaÃ±ol </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005055.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD005055.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;ÚÚ©ÛØ¯Ù&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en tÃ©rminos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;Ø®ÙØ§ØµÙ Ø¨Ù Ø²Ø¨Ø§Ù Ø³Ø§Ø¯Ù&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD005055.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD005055.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD005055.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD005055.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views:Â </span> <span>3178 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD005055.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005055.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005055.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005055.pub3/full#CD005055-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005055.pub3/full#CD005055-sec-0096"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005055.pub3/full#CD005055-sec-0015"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005055.pub3/full#CD005055-sec-0016"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005055.pub3/full#CD005055-sec-0021"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005055.pub3/full#CD005055-sec-0022"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005055.pub3/full#CD005055-sec-0052"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005055.pub3/full#CD005055-sec-0090"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005055.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005055.pub3/appendices#CD005055-sec-0101"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005055.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005055.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/table_n/CD005055StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/table_n/CD005055StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005055.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005055.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005055.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005055.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005055.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD005055.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright Â© 2014 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005055.pub3/information#CD005055-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Matthew Bizzarro</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005055.pub3/information#CD005055-cr-0003">Ian Gross</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005055.pub3/information#CD005055-cr-0004">Fabiano T Barbosa</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/information/en#CD005055-sec-0109">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 03 July 2014 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD005055.pub3">https://doi.org/10.1002/14651858.CD005055.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD005055-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005055-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD005055-abs-0004">EspaÃ±ol</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005055-abs-0006">ÙØ§Ø±Ø³Û</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD005055-abs-0001" lang="en"> <section id="CD005055-sec-0001"> <h3 class="title" id="CD005055-sec-0001">Background</h3> <p>Nitric oxide (NO) is a prevalent molecule in humans that is responsible for many physiologic activities including pulmonary vasodilation. An exogenous, inhaled form (iNO) exists that mimics this action without affecting systemic blood pressure. This therapy has been implemented in the treatment of pulmonary hypertension. This review examines the efficacy of iNO in the postoperative management of infants and children with congenital heart disease (CHD). The original review was published in 2005, updated in 2008 and again in 2014. </p> </section> <section id="CD005055-sec-0002"> <h3 class="title" id="CD005055-sec-0002">Objectives</h3> <p>To compare the effects of postoperative administration of iNO versus placebo or conventional management, or both, on infants and children with CHD and pulmonary hypertension. The primary outcome was mortality. Secondary outcomes included length of hospital stay; neurodevelopmental disability; number of pulmonary hypertensive crises (PHTC); changes in mean pulmonary arterial pressure (MPAP), mean arterial pressure (MAP), and heart rate (HR); changes in oxygenation measured as the ratio of arterial oxygen tension (PaO<sub>2</sub>) to fraction of inspired oxygen (FiO<sub>2</sub>); and measurement of maximum methaemoglobin level as a marker of toxicity. </p> </section> <section id="CD005055-sec-0003"> <h3 class="title" id="CD005055-sec-0003">Search methods</h3> <p>In this updated version we extended the CENTRAL search to 2013, Issue 12 of <i>The Cochrane Library</i>, and MEDLINE and EMBASE through to 1 December 2013. The original search was performed in July 2004 and again in November 2007. We included abstracts and all languages. </p> </section> <section id="CD005055-sec-0004"> <h3 class="title" id="CD005055-sec-0004">Selection criteria</h3> <p>We included randomized and quasiârandomized controlled trials comparing iNO with placebo or conventional management, or both. Trials included only children with CHD requiring surgery complicated by pulmonary hypertension. </p> </section> <section id="CD005055-sec-0005"> <h3 class="title" id="CD005055-sec-0005">Data collection and analysis</h3> <p>Two authors extracted data. Data were collected on mortality; number of PHTC; changes in MPAP, MAP, HR, and PaO<sub>2</sub>:FiO<sub>2</sub>; and maximum methaemoglobin level. Data on longâterm mortality, neurodevelopmental disability, and length of hospital stay were unavailable. We performed subgroup analysis by method of control (placebo or conventional management). </p> </section> <section id="CD005055-sec-0006"> <h3 class="title" id="CD005055-sec-0006">Main results</h3> <p>We reran the searches to December 2013 and identified three new studies. These three studies did not fulfil our inclusion criteria. Therefore, no new studies were included in this updated review. In total four randomized trials involving 210 participants were included in this review. We observed no differences in mortality (OR 1.67, 95% CI 0.38 to 7.30; P = 0.50); PHTC (OR 0.80, 95% CI 0.15 to 4.18; P = 0.79); changes in MPAP (treatment effect â2.94 mm Hg, 95% CI â9.28 to 3.40; P = 0.36), MAP (treatment effect â3.55 mm Hg, 95% CI â11.86 to 4.76; P = 0.40), HR (treatment effect 0.02 bpm, 95% CI â8.13 to 8.18; P = 1.00), or PaO<sub>2</sub>:FiO<sub>2</sub> (mean difference 17.18, 95% CI â28.21 to 62.57; P = 0.46). There was a significant increase in the methaemoglobin level (mean difference 0.30%, 95% CI 0.24 to 0.36; P &lt; 0.00001) in patients treated with iNO, although levels did not reach toxicity levels. Data from longâterm mortality, neurodevelopmental disability, and length of stay were not available. Two trials had a low risk of bias. Very low quality of the evidence was observed considering grading of the outcomes. </p> </section> <section id="CD005055-sec-0007"> <h3 class="title" id="CD005055-sec-0007">Authors' conclusions</h3> <p>We observed no differences with the use of iNO in the outcomes reviewed. No data were available for several clinical outcomes including longâterm mortality and neurodevelopmental outcome. We found it difficult to draw valid conclusions given concerns regarding methodologic quality, sample size, and heterogeneity. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD005055-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005055-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD005055-abs-0005">EspaÃ±ol</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005055-abs-0007">ÙØ§Ø±Ø³Û</a> </li> <li class="section-language"> <a class="" href="full/ms#CD005055-abs-0003">Bahasa Malaysia</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD005055-abs-0002" lang="en"> <h3>Inhaled nitric oxide to treat high blood pressure of the pulmonary vessels after surgery in infants and children with congenital heart disease </h3> <p><b>Review question</b> </p> <p>We reviewed the evidence on the effectiveness of inhaled nitric oxide for treatment of high blood pressure in the pulmonary vessels in infants and children born with heart disease. </p> <p><b>Background</b> </p> <p>Pulmonary hypertension (PH) is an increase in blood pressure in the pulmonary vessels that affects various patient populations and can cause poor health and a significant number of deaths. PH can reduce cardiac function and precipitate a lifeâthreatening crisis. Congenital heart disease (CHD) is a structural deformity of the heart that exists at birth, and often before birth. PH may arise because of increased pulmonary blood flow and persistent raised pulmonary arterial pressures, or following the use of cardiopulmonary bypass during surgical repair. Inhaled nitric oxide (iNO) is a therapy which causes a selective reduction in the high blood pressure of the pulmonary vessels without decreasing blood pressure in the rest of the body and, therefore, may have a treatment benefit in children with heart disease. In this review, we aimed to assess the benefits and harms of using iNO for postoperative management of PH in children with CHD. </p> <p><b>Study characteristics</b> </p> <p>The evidence was current to December 2013. We found four randomized clinical trials involving 210 participants aged from one day to 17 years with PH either in the preoperative (one study) or postoperative period (three studies). Control groups received conventional management therapy (two trials) or nitrogen gas as placebo (two trials). Two trials compared changes in systemic and pulmonary arterial blood pressure and heart rate (haemodynamics). The other two trials compared the number of pulmonary hypertensive crises and deaths, with changes in haemodynamic measurements as secondary outcomes. </p> <p><b>Key results</b> </p> <p>We found no differences between the groups of patients who received iNO and those that did not. Two trials reported on deaths before discharge, with none occurring in one of the trials. We observed no differences in the number of deaths (two trials); pulmonary hypertensive crises (one trial); changes in mean pulmonary arterial pressure (three trials), arterial pressure (three trials), or heart rate (HR) (three trials); or changes in oxygenation of the blood (one trial). However, no trials reported longâterm deaths or neurodevelopmental disability. In addition, no data were available for analysis of length of hospital stay. </p> <p>Although iNO has been studied as a postsurgical therapy in children with heart disease in order to assist recovery, this review showed no benefits with its use. </p> <p><b>Quality of the evidence</b> </p> <p>Two trials had a low risk of bias. The quality of the evidence was, however, very low due to the small number of participants and low event rates. All trials utilized different concentrations of iNO, different durations of administration initiated at different times after the operation, and included patients with diverse congenital heart defects necessitating repair. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD005055-sec-0096" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD005055-sec-0096"></div> <h3 class="title" id="CD005055-sec-0097">Implications for practice</h3> <section id="CD005055-sec-0097"> <p>The results of this metaâanalysis do not appear to show any significant clinical benefit with the use of postoperative iNO to treat pulmonary hypertension in children with CHD. We have observed no differences with respect to mortality, number of PHTC, arterial oxygenation, or changes in haemodynamics with the use of postoperative iNO. There are no data to determine the effects of treatment with iNO on length of stay in an ICU or hospital, longâterm mortality, or neurodevelopmental disability. Furthermore, the relatively sparse patient population and the potential biases that may be present as a result of problems with the methodology of the trials make it impossible to draw any valid conclusions about treatment effect at this time. </p> </section> <h3 class="title" id="CD005055-sec-0098">Implications for research</h3> <section id="CD005055-sec-0098"> <p>It is evident from this review that more data from randomized controlled trials of high methodologic quality are necessary in order to appropriately evaluate the therapeutic potential of iNO in this clinical setting. Also, although the outcomes reviewed in these trials are of clinical importance, more relevant outcomes need to be assessed. In particular, additional patient data with respect to mortality; length of ICU and hospital stay, or both; neurodevelopmental outcomes; and measures of oxygenation necessitate further investigation. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD005055-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD005055-sec-0015"></div> <div class="table" id="CD005055-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span>Â <span class="table-title">Inhaled nitric oxide compared to placebo or conventional therapy for all infants and children with congenital heart disease having postoperative management of pulmonary hypertension</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Inhaled nitric oxide compared to placebo or conventional therapy for all infants and children with congenital heart disease having postoperative management of pulmonary hypertension</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> all infants and children with congenital heart disease having postoperative management of pulmonary hypertension<br/> <b>Settings:</b> postoperative<br/> <b>Intervention:</b> inhaled nitric oxide<br/> <b>Comparison:</b> placebo or conventional therapy </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Placebo or conventional therapy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Inhaled nitric oxide</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Longâterm mortality</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>0<br/> (0) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>No studies met outcome definition</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Mortality prior to discharge</b><sup>1</sup> <br/> Followâup: mean 15 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 1.67</b> <br/> (0.38 to 7.3) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>162<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>ââââ<br/> <b>very low</b><sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>37 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>60 per 1000</b> <br/> (14 to 219) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>41 per 1000</b> <br/> (10 to 158) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Difference in MPAP change score (SE) â Conventional Management</b><sup>4</sup> <br/> Followâup: mean 5 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/> <b>very low</b><sup>4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â1.14 (â8.87 to 6.59)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Difference in MPAP change score (SE) â Placebo</b><sup>4</sup> <br/> Followâup: mean 5 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable<sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/> <b>very low</b><sup>6,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â9.15 (â20.7 to 2.4)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Difference in MAP change score (SE) â Conventional Mangement</b><sup>4</sup> <br/> Followâup: mean 5 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/> <b>very low</b><sup>4,5,8</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â1.94 (â11.23 to 7.35)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Difference in MAP change score (SE) â Placebo</b><sup>4</sup> <br/> Followâup: mean 5 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable<sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/> <b>very low</b><sup>6,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â10 (â28.6 to 8.6)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> One of the two trials had zero events (<a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>).<br/> <sup>2</sup> Statistical heterogeneity could not be measured. One of the two trials had zero events (<a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>).<br/> <sup>3</sup> There was very low precision because of the small numbers and the low rate of events (only 162 patients and 8 events). One of the two trials had zero events (<a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>).<br/> <sup>4</sup> Preâspecified subgroup analysis.<br/> <sup>5</sup> One of the two trials included was assessed as having a low risk of bias (<a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>).<br/> <sup>6</sup> Preâspecified subgroup analysis. Study was assessed as having high risk of bias (<a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a>).<br/> <sup>7</sup> Statistical heterogeneity could not be measured.<br/> <sup>8</sup> There was very low precision because of the small numbers (only 50 patients). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD005055-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD005055-sec-0016"></div> <section id="CD005055-sec-0017"> <h3 class="title" id="CD005055-sec-0017">Description of the condition</h3> <p>The efficacy of iNO has been extensively investigated and substantiated in the treatment of persistent pulmonary hypertension of the newborn (<a href="./references#CD005055-bbs2-0016" title="ClarkRH , KueserTJ , WalkerMW , SouthgateWM , HuckabyJL , PerezJA , et al. Lowâdose nitric oxide therapy for persistent pulmonary hypertension of the newborn. New England Journal of Medicine2000;342(7):469â74. [MEDLINE: 10675427] ">Clark 2000</a>; <a href="./references#CD005055-bbs2-0027" title="KinsellaJP , NeishSR , ShafferE , AbmanSH . Lowâdose inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet1992;340(8823):819â20. [MEDLINE: 1357246] ">Kinsella 1992</a>; <a href="./references#CD005055-bbs2-0031" title="Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in fullâterm and nearly fullâterm infants with hypoxic respiratory failure. New England Journal of Medicine1997;336(9):597â604. [MEDLINE: 9036320] ">NINOS 1997</a>; <a href="./references#CD005055-bbs2-0033" title="RobertsJD , PolanerDM , LangP . Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet1992;340(8823):818â9. [MEDLINE: 1357245] ">Roberts 1992</a>; <a href="./references#CD005055-bbs2-0034" title="RobertsJD , FinemanJR , MorinFC , ShawlPW , RimarS , SchreiberMD , et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. New England Journal of Medicine1997;336(9):605â10. [MEDLINE: 9032045] ">Roberts 1997</a>). The extreme vasoreactivity of the newborn pulmonary vasculature to inhaled nitric oxide (iNO) has raised the question of whether or not iNO would be an effective treatment for pulmonary hypertension in more diverse populations and clinical scenarios (<a href="./references#CD005055-bbs2-0023" title="HaworthSG . Pulmonary vascular disease in different types of congenital heart disease. Implications for interpretation of lung biopsy findings in early childhood. British Heart Journal1984;52(5):557â71. [MEDLINE: 6498033] ">Haworth 1984</a>; <a href="./references#CD005055-bbs2-0035" title="SteudelW , HurfordWE , ZapolWM . Inhaled nitric oxide. Basic biology and clinical applications. Anesthesiology1999;91(4):1090â121. [MEDLINE: 10519513] ">Steudel 1999</a>). For example, pulmonary hypertension may arise in patients with congenital heart disease (a structural deformity in the heart existing at birth and often before birth) (CHD) characterized by increased pulmonary blood flow. The increased circulation can potentiate remodeling of the vascular bed resulting in persistence of elevated pulmonary arterial pressure, which accelerates the need for operative intervention and potentially complicates postoperative recovery (<a href="./references#CD005055-bbs2-0013" title="AtzAM , WesselDL . Inhaled nitric oxide in the neonate with cardiac disease. Seminars in Perinatology1997;21(5):441â55. [MEDLINE: 9352616] ">Atz 1997</a>; <a href="./references#CD005055-bbs2-0036" title="WesselDL , AdatiaI , GigliaTM , ThompsonJE , KulikTJ . Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation1993;88 Suppl 1:2128â38. [MEDLINE: 8222107] ">Wessel 1993</a>). Pulmonary hypertension can occur in about 50% of CHD cases (<a href="./references#CD005055-bbs2-0022" title="GorenfloM , GuH , XuZ . Periâoperative pulmonary hypertension in paediatric patients: current strategies in children with congenital heart disease. Cardiology2010;116(1):10â7. [MEDLINE: 20424447] ">Gorenflo 2010</a>). Endogenous production of nitric oxide is compromised in the early postoperative period and the use of cardiopulmonary bypass during surgical repair can contribute to elevated pulmonary arterial pressures through induction of hypoxaemia, production of microemboli, and excess production of endothelin and thromboxane (<a href="./references#CD005055-bbs2-0013" title="AtzAM , WesselDL . Inhaled nitric oxide in the neonate with cardiac disease. Seminars in Perinatology1997;21(5):441â55. [MEDLINE: 9352616] ">Atz 1997</a>). These factors may result in acute elevations in pulmonary vascular resistance that can impede cardiac output and precipitate lifeâthreatening crises (<a href="./references#CD005055-bbs2-0025" title="JonesOD , ShoreDF , RigbyML , LeijalaM , ScallanJ , ShinebourneEA , et al. The use of tolazoline hydrochloride as a pulmonary vasodilator in potentially fatal episodes of pulmonary vasoconstriction after cardiac surgery in children. Circulation1981;64(2 Part 2):II134â9. [MEDLINE: 7249314] ">Jones 1981</a>; <a href="./references#CD005055-bbs2-0037" title="WhellerJ , GeorgeBL , MulderDG , JarmakaniJM . Diagnosis and management of postoperative pulmonary hypertensive crisis. Circulation1979;60(7):1640â4. [MEDLINE: 498483] ">Wheller 1979</a>). These events occur postoperatively in approximately 7% of patients with CHD, with an associated mortality rate of about 29% (<a href="./references#CD005055-bbs2-0014" title="BandoK , TurrentineMW , SharpTG , SekineY , AufieroTX , SunK , et al. Pulmonary hypertension after operations for congenital heart disease: analysis of risk factors and management. Journal of Thoracic and Cardiovascular Surgery1996;112(6):1600â9. [MEDLINE: 8975852] ">Bando 1996</a>). As a result, researchers and clinicians have investigated the use of iNO in the postoperative management of CHD as a means of reducing pulmonary vascular resistance and averting such complications. </p> </section> <section id="CD005055-sec-0018"> <h3 class="title" id="CD005055-sec-0018">Description of the intervention</h3> <p>Nitric oxide is a molecule that is produced throughout the human body and has a diversity of physiologic actions. One of interest involves its role as a mediator of vasodilation. Within vascular endothelial cells nitric oxide synthase converts Lâarginine into nitric oxide (NO). NO then diffuses into vascular smooth muscle where it binds to soluble guanylate cyclase to convert guanosine triphosphate into cyclic guanosine monophosphate (cGMP). The cGMP then mediates vascular smooth muscle relaxation (<a href="./references#CD005055-bbs2-0035" title="SteudelW , HurfordWE , ZapolWM . Inhaled nitric oxide. Basic biology and clinical applications. Anesthesiology1999;91(4):1090â121. [MEDLINE: 10519513] ">Steudel 1999</a>). Exogenous NO in the form of iNO has a similar mechanism of action on the pulmonary vascular bed. After initiating vascular smooth muscle relaxation the molecule diffuses into the bloodstream where it binds with iron in haemoglobin to form methaemoglobin and is inactivated (<a href="./references#CD005055-bbs2-0035" title="SteudelW , HurfordWE , ZapolWM . Inhaled nitric oxide. Basic biology and clinical applications. Anesthesiology1999;91(4):1090â121. [MEDLINE: 10519513] ">Steudel 1999</a>). Therefore, the molecule exerts virtually no vasodilatory effect on the systemic circulation. It is this unique property of iNO that has led to the investigation of its use in a myriad of paediatric and adult diseases complicated by pulmonary hypertension (<a href="./references#CD005055-bbs2-0030" title="NelinLD , HoffmanGM . The use of inhaled nitric oxide in a wide variety of clinical problems. Pediatric Clinics of North America1998;45(3):531â48. [MEDLINE: 9653435] ">Nelin 1998</a>). </p> </section> <section id="CD005055-sec-0019"> <h3 class="title" id="CD005055-sec-0019">How the intervention might work</h3> <p>In 1994, Journois et al studied 17 infants with CHD and critical postoperative pulmonary arterial hypertension that was unresponsive to conventional therapies. Initiation of 20 parts per million (ppm) of iNO resulted in a decrease in mean pulmonary arterial pressure (MPAP) in all patients without significant changes in systemic arterial pressure (<a href="./references#CD005055-bbs2-0026" title="JournoisD , PouardP , MauriatP , MalhereT , VouheP , SafranD . Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart disease. Journal of Thoracic and Cardiovascular Surgery1994;107(4):1129â35. [MEDLINE: 8159035] ">Journois 1994</a>). Similar findings were published by Miller et al in a case series of 10 infants with CHD who were administered low dose (2, 10, 20 ppm) iNO in the postoperative period. In infants with a high ratio of pulmonary to systemic arterial pressure there was a significant reduction in mean pulmonary vascular resistance with a subsequent rise in cardiac output (<a href="./references#CD005055-bbs2-0029" title="MillerOI , CelermajerDS , DeanfieldJE , MacraeDJ . Very lowâdose inhaled nitric oxide: a selective pulmonary vasodilator after operations for congenital heart disease. Journal of Thoracic and Cardiovascular Surgery1994;108(3):487â94. [MEDLINE: 8078341] ">Miller 1994</a>). A 1995 case series by Beghetti et al also demonstrated a reduction in pulmonary artery pressure and an increase in arterial oxygen saturation without significant alteration in systemic vascular resistance with the use of continuous iNO in the postoperative period (<a href="./references#CD005055-bbs2-0015" title="BeghettiM , HabreW , BernerM . Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in paediatric patients. British Heart Journal1995;73(1):65â8. [MEDLINE: 7888265] ">Beghetti 1995</a>). Around the same time, Curran et al demonstrated a minimal benefit of iNO in patients who had undergone atrioventricular canal repair and a significant reduction in pulmonary artery pressure in those with pulmonary hypertension refractory to conventional therapies (that is hyperventilation, hyperoxygenation, and intravenous inotropic support) (<a href="./references#CD005055-bbs2-0018" title="CurranRD , MavroudisC , BackerCL , SautelM , ZalesVR , WesselDL . Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension. Annals of Thoracic Surgery1995;60(6):1765â71. [MEDLINE: 8787478] ">Curran 1995</a>). </p> </section> <section id="CD005055-sec-0020"> <h3 class="title" id="CD005055-sec-0020">Why it is important to do this review</h3> <p>As a result of the findings described above (<a href="./references#CD005055-bbs2-0015" title="BeghettiM , HabreW , BernerM . Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in paediatric patients. British Heart Journal1995;73(1):65â8. [MEDLINE: 7888265] ">Beghetti 1995</a>; <a href="./references#CD005055-bbs2-0018" title="CurranRD , MavroudisC , BackerCL , SautelM , ZalesVR , WesselDL . Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension. Annals of Thoracic Surgery1995;60(6):1765â71. [MEDLINE: 8787478] ">Curran 1995</a>; <a href="./references#CD005055-bbs2-0026" title="JournoisD , PouardP , MauriatP , MalhereT , VouheP , SafranD . Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart disease. Journal of Thoracic and Cardiovascular Surgery1994;107(4):1129â35. [MEDLINE: 8159035] ">Journois 1994</a>; <a href="./references#CD005055-bbs2-0029" title="MillerOI , CelermajerDS , DeanfieldJE , MacraeDJ . Very lowâdose inhaled nitric oxide: a selective pulmonary vasodilator after operations for congenital heart disease. Journal of Thoracic and Cardiovascular Surgery1994;108(3):487â94. [MEDLINE: 8078341] ">Miller 1994</a>), several investigators undertook randomized controlled trials (RCTs) to more effectively evaluate the use of iNO in the treatment of pulmonary hypertension in the immediate postoperative period for paediatric patients with CHD. There is a clinical guideline recommending iNO for neonates with acute hypoxic respiratory failure (<a href="./references#CD005055-bbs2-0019" title="DiBlasiRM , MyersTR , HessDR . Evidenceâbased clinical practice guideline: inhaled nitric oxide for neonates with acute hypoxic respiratory failure. Respiratory Care2010;55(12):1717â45. [MEDLINE: 21122181] ">DiBlasi 2010</a>). Although iNO has been recommended to treat neonates with acute hypoxaemic respiratory failure complicated by pulmonary artery hypertension, its use in other clinical scenarios and patient populations, including infants and children with CHD complicated by pulmonary hypertension, remains uncertain so this systematic review is relevant to answer the research question: what are the effects of postoperative iNO versus placebo or conventional management, or both, on infants and children with CHD? </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD005055-sec-0021" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD005055-sec-0021"></div> <p>To compare the effects of postoperative administration of iNO versus placebo or conventional management, or both, on infants and children with CHD and pulmonary hypertension. We evaluated: </p> <p> <ol id="CD005055-list-0001"> <li> <p>longâterm mortality;</p> </li> <li> <p>mortality prior to hospital discharge;</p> </li> <li> <p>length of intensive care unit or hospital stay;</p> </li> <li> <p>neurodevelopmental disability (a disorder of brain functionthat affects emotion, learning ability, and memory); </p> </li> <li> <p>pulmonary hypertensive crises (PHTC);</p> </li> <li> <p>MPAP, mean arterial (systemic) pressure (MAP), and heart rate (HR);</p> </li> <li> <p>arterial oxygenation (the amount of oxygen in arterial blood) or saturation (nonâinvasive measurement of oxygen in arterial blood), or both; </p> </li> <li> <p>methaemoglobin level (an abnormal form of haemoglobin that cannot bind oxygen).</p> </li> </ol> </p> <p>We performed subgroup analysis to observe the effects of iNO by method of control (for example placebo versus use of conventional management). </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD005055-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD005055-sec-0022"></div> <section id="CD005055-sec-0023"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD005055-sec-0024"> <h4 class="title">Types of studies</h4> <p>We evaluated randomized controlled trials (RCTs) and quasiârandomized controlled trials that compared the use of iNO with placebo or conventional management strategies, or both, and included at least one outcome of interest. We considered both parallel and crossâover design trials for inclusion. </p> </section> <section id="CD005055-sec-0025"> <h4 class="title">Types of participants</h4> <p>We included infants and children aged one day to 14 years with CHD requiring surgical repair and with evidence of pulmonary hypertension in the preâ or postoperative period. We excluded preterm neonates. </p> </section> <section id="CD005055-sec-0026"> <h4 class="title">Types of interventions</h4> <p>We evaluated the use of iNO at various concentrations ranging from five to 80 ppm when given in the postoperative period. </p> <p>We evaluated placebo, administered as nitrogen gas (N<sub>2</sub>), as a control. </p> <p>Conventional management included hyperventilation to induce respiratory alkalosis, use of sodium bicarbonate to induce metabolic alkalosis, use of intravenous inotropic and vasodilatory agents, and use of intravenous sedatives and neuromuscular blockade in an attempt to improve pulmonary blood flow (<a href="./references#CD005055-bbs2-0038" title="WhittsettJA , PryhuberGS , RiceWR , WarnerBB , WertSE . Acute respiratory disorders. In: AveryGB , FletcherMA , MacDonaldMG editor(s). Neonatology. Pathophysiology and Management of the Newborn. 5th Edition. Philadelphia: Lippincott, Williams, &amp; Wilkins, 1999:499â500. ">Whittsett 1999</a>). </p> </section> <section id="CD005055-sec-0027"> <h4 class="title">Types of outcome measures</h4> <section id="CD005055-sec-0028"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD005055-list-0002"> <li> <p>Longâterm mortality</p> </li> <li> <p>Mortality prior to discharge</p> </li> </ol> </p> </section> <section id="CD005055-sec-0029"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD005055-list-0003"> <li> <p>Length of stay in intensive care unit or hospital</p> </li> <li> <p>Incidence and severity of neurodevelopmental disability</p> </li> <li> <p>Incidence of PHTC</p> </li> <li> <p>Change in MPAP</p> </li> <li> <p>Change in MAP</p> </li> <li> <p>Change in HR</p> </li> <li> <p>Change in ratio of arterial oxygen tension (PaO<sub>2</sub>) to fraction of inspired oxygen (FiO<sub>2</sub>) </p> </li> <li> <p>Maximum methaemoglobin level</p> </li> </ol> </p> </section> </section> </section> <section id="CD005055-sec-0030"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD005055-sec-0031"> <h4 class="title">Electronic searches</h4> <p>In our original review we searched the Cochrane Central Register of Controlled Trials (CENTRAL) (<i>The Cochrane Library</i> 2004, Issue 3), MEDLINE (January 1966 to 1 July 2004) and EMBASE (January 1980 to 1 July 2004) (<a href="./references#CD005055-bbs2-0039" title="BizzarroM , GrossI . Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease. Cochrane Database of Systematic Reviews2005, Issue 4. [DOI: 10.1002/14651858.CD005055.pub2] ">Bizzarro 2005</a>). For our first update, the search was extended from 1 July 2004 through to 1 November 2007. </p> <p>In this latest updated version we searched CENTRAL through to 2013, Issue 12 of <i>The Cochrane Library</i>, and MEDLINE and EMBASE through to 1 December 2013. We used filters to identify RCTs in MEDLINE (<a href="./references#CD005055-bbs2-0020" title="DickersinK , SchererR , LefebvreC . Identifying relevant studies for systematic reviews. BMJ1994;309:1286â9. [MEDLINE: 7718048] ">Dickersin 1994</a>) and EMBASE (<a href="./references#CD005055-bbs2-0028" title="LefebvreC , McDonaldS . Development of a sensitive search strategy for reports of randomized controlled trials in EMBASE. Paper presented at the Fourth International Cochrane Colloquium. 20â24 October, 1996. ">Lefebvre 1996</a>). We limited the searches to studies in humans. We did not apply any language restrictions during the literature search or for trial inclusion. We included abstracts in this search and handsearched conference abstracts for relevant studies. We retrieved all eligible studies in full text. </p> <p>The strategy for CENTRAL is in <a href="./appendices#CD005055-sec-0102">Appendix 1</a>.<br/> The strategy for MEDLINE is in <a href="./appendices#CD005055-sec-0103">Appendix 2</a>.<br/> The strategy for EMBASE in <a href="./appendices#CD005055-sec-0104">Appendix 3</a>. </p> </section> <section id="CD005055-sec-0032"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists of identified review articles and all included studies in an attempt to identify other potentially eligible studies. We undertook personal communication with primary authors to identify unpublished data, when necessary. </p> </section> </section> <section id="CD005055-sec-0033"> <h3 class="title" id="CD005055-sec-0033">Data collection and analysis</h3> <section id="CD005055-sec-0034"> <h4 class="title">Selection of studies</h4> <p>We utilized the standardized methods for conducting a systematic review as described by The Cochrane Collaboration in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> 5.1.0 (<a href="./references#CD005055-bbs2-0024" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochraneâhandbook.org. ">Higgins 2011</a>). Two authors independently read the RCTs identified through searching electronic databases and handsearching of journals. Using the inclusion and exclusion criteria defined above, the authors reached consensus as to which studies were included in the review. </p> </section> <section id="CD005055-sec-0035"> <h4 class="title">Data extraction and management</h4> <p>Two authors (MB and IG) independently extracted and collected data on a paper form (<a href="./appendices#CD005055-sec-0105">Appendix 4</a>). We contacted the authors of trials, when necessary, to obtain raw data not presented in the trial report but necessary for the analysis. We resolved any discrepancies in a consensus meeting. </p> </section> <section id="CD005055-sec-0036"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two authors (MB and IG) independently assessed the methodologic quality of each included trial following the guidelines described by The Cochrane Collaboration in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> 5.1.0 (<a href="./references#CD005055-bbs2-0024" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochraneâhandbook.org. ">Higgins 2011</a>). A copy of the form that we used to do this assessment is in <a href="./appendices#CD005055-sec-0105">Appendix 4</a>. We resolved any discrepancies in this assessment by a consensus meeting. No thirdâparty intervention was required. We used the 'risk of bias' tool in <a href="./references#CD005055-bbs2-0032" title="RevMan5.2 . Review Manager (RevMan) [Computer program]. Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 5.2</a> (<a href="./references#CD005055-bbs2-0032" title="RevMan5.2 . Review Manager (RevMan) [Computer program]. Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 5.2</a>). We assessed the risk of bias (when there is an error in the conduct of the trial that could lead to a misleading result) based on the information presented in the papers. We did not contact authors for clarification. We used the following as the assessment criteria. </p> <section id="CD005055-sec-0037"> <h5 class="title">1. Random sequence generation</h5> <p>Low: sequence generation was reported using computer generated random numbers, codes or sealed envelopes. We judged other processes, such as tossing of a coin, as adequate if the whole sequence was generated prior to the start of the trial and if it was performed by a person not otherwise involved in patient recruitment. </p> <p>High: a system was used which was generated by a nonârandom approach, e.g. dates, names or identification numbers. </p> <p>Unclear: insufficient information was available to consider 'low' or 'high' risk of bias. </p> </section> <section id="CD005055-sec-0038"> <h5 class="title">2. Allocation concealment</h5> <p>Low: if the process that was used prevented patient recruiters, investigators, and participants from knowing the intervention allocation of the next participant to be enrolled in the study. </p> <p>High: if the allocation method allowed the patient recruiters, investigators, or participants to know the treatment allocation of the next participant to be enrolled in the study. </p> <p>Unclear: insufficient information was available to consider 'low' or 'high' risk of bias. </p> </section> <section id="CD005055-sec-0039"> <h5 class="title">3. Blinding of participants and personnel</h5> <p>Low: if participants and personnel were reported as blinded.</p> <p>High: if participants and personnel were not reported as blinded.</p> <p>Unclear: insufficient information was available to consider 'low' or 'high' risk of bias. </p> </section> <section id="CD005055-sec-0040"> <h5 class="title">4. Blinding of outcome assessment</h5> <p>Low: if outcome assessors were reported as blinded.</p> <p>High: if outcome assessors were not reported as blinded.</p> <p>Unclear: insufficient information was available to consider 'low' or 'high' risk of bias. </p> </section> <section id="CD005055-sec-0041"> <h5 class="title">5. Incomplete outcome data</h5> <p>Low: numbers of withdrawals or exclusions per group, with reasons, were provided or if the authors reported no withdrawals or exclusions. </p> <p>High: numbers of withdrawals or exclusions per group, with reasons, were not provided or if authors did not report reasons for withdrawals or exclusions per group when they were evident. </p> <p>Unclear: insufficient information was available to consider 'low' or 'high' risk of bias. </p> </section> <section id="CD005055-sec-0042"> <h5 class="title">6. Selective reporting</h5> <p>Low: if all outcomes were reported.</p> <p>High: if outcomes were measured but not reported or planned and not measured.</p> <p>Unclear: insufficient information was available to consider 'low' or 'high' risk of bias. </p> </section> <section id="CD005055-sec-0043"> <h5 class="title">7. Other bias</h5> <p>Low: if the study appeared to be free of other sources of bias not described in other sections of this table. </p> <p>High: if the study appeared to be fraudulent or had some other problem not described in other sections of this table. </p> <p>Unclear: insufficient information was available to consider 'low' or 'high' risk of bias. </p> </section> </section> <section id="CD005055-sec-0044"> <h4 class="title">Measures of treatment effect</h4> <p>With respect to data analysis, we employed the standardized methods of the Cochrane Neonatal Review Group (<a href="./references#CD005055-bbs2-0017" title="Cochrane Neonatal Review Group. Organization of a systematic review for the Cochrane Neonatal Review Group. Guidelines for reviewers and editors. www.cochrane.mcmaster.ca/neonatal/. ">CNRG 2004</a>). These included, but were not limited to: </p> <p> <ol id="CD005055-list-0004"> <li> <p>considering which types of study design were appropriate for the review and deciding how to address each type; </p> </li> <li> <p>determining the likely nature of the outcome data (that is, dichotomous, continuous, etc); </p> </li> <li> <p>considering whether it was possible to specify in advance what treatment effect measures were used; </p> </li> <li> <p>deciding how to identify statistical heterogeneity;</p> </li> <li> <p>deciding whether to use randomâeffects metaâanalyses, fixedâeffect metaâanalyses, or both methods; </p> </li> <li> <p>considering how to assess clinical and methodological diversity (heterogeneity) and whether (and how) to incorporate these into the analysis strategy; </p> </li> <li> <p>deciding how to assess and address the quality of included studies in the analysis; and </p> </li> <li> <p>deciding whether (and how) to seek evidence of possible publication or reporting biases.</p> </li> </ol> </p> <p>We identified pertinent data from trials of both parallel (<a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>; <a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a>; <a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a>) and crossâover (<a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a>) design. When the outcome of interest included only dichotomous data from parallel trials, we calculated an odds ratio (OR) with 95% confidence interval (CI) using a fixedâeffect model. When the outcome of interest included only continuous data from parallel trials, we calculated a mean difference (MD) with 95% CI using a fixedâeffect model. When the outcome of interest included data from both parallel and crossâover trials, we employed the generic inverse variance method to analyse these combinations of data. Before any of these methods could be utilized, we collected and assessed individual patient data. We collected baseline measurements of MPAP, MAP, HR, and the ratio of PaO<sub>2</sub>:FiO<sub>2</sub> for each individual patient and compared them with measurements taken at the completion of therapy. We then calculated a mean change score with standard deviation for both the treatment and control groups. We calculated a reduction in any of the above outcomes from baseline as a negative change score, whereas we calculated an increase from baseline as a positive change score. Individual patient data were available from <a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a> and <a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a>; and we obtained data direct from the authors of <a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>. When necessary, we calculated MPAP from available individual patient pulmonary systolic and diastolic pressures. In <a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a>, individual patient data were presented as the baseline MPAP of each patient and the subsequent per cent change in MPAP from baseline after initiation of therapy. Using the per cent change from the initial MPAP, the final MPAP and change score could be calculated for each patient. For the change in HR and MAP in <a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a>, we calculated a change score from the available baseline and postâtreatment mean values. To calculate the standard deviation (SD) we utilized the methods described by The Cochrane Collaboration in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> 5.1.0 (Section 7.7.3.2) (<a href="./references#CD005055-bbs2-0024" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochraneâhandbook.org. ">Higgins 2011</a>). First, we imputed correlation coefficients for both the treatment and control groups from <a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>. We chose this study because it was most similar to <a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a> (the <a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a> trial being of crossâover design). Next, we calculated the SD for both the control and treatment group utilizing the corresponding correlation coefficient and the available data. </p> </section> <section id="CD005055-sec-0045"> <h4 class="title">Unit of analysis issues</h4> <p>We did not have any unit of analysis issues.</p> </section> <section id="CD005055-sec-0046"> <h4 class="title">Dealing with missing data</h4> <p>We contacted the trial authors to clarify missing or unclear data when necessary.</p> </section> <section id="CD005055-sec-0047"> <h4 class="title">Assessment of heterogeneity</h4> <p>We performed testing for heterogeneity of treatment effect using a Chi<sup>2</sup> test. We also employed the I<sup>2</sup> statistic and Chi<sup>2</sup> test to measure the degree of inconsistency among results. We considered data highly suspicious if we identified an I<sup>2</sup> value greater than 50% and, under these circumstances, data were reanalysed using a randomâeffects model. </p> </section> <section id="CD005055-sec-0048"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to assess publication bias using a funnel plot (<a href="./references#CD005055-bbs2-0024" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochraneâhandbook.org. ">Higgins 2011</a>) if more than nine studies were included in the metaâanalysis. The funnel plot has an inverted funnel shape if publication bias is absent; funnel plots are examined visually and through Egger's test to test asymmetry. </p> </section> <section id="CD005055-sec-0049"> <h4 class="title">Data synthesis</h4> <p>In order to combine and analyse data from both parallel and crossâover trials, we first calculated treatment effects and 95% CIs for both the continuous and dichotomous data. For continuous data, we calculated an MD with 95% CI using a fixedâeffect model for each outcome described. For dichotomous data, we calculated an OR with 95% CI using a fixedâeffect model. Next, we calculated a standard error (SE) for each outcome of interest using the 95% CI and a value from the tâdistribution as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> 5.1.0 (Section 7.7.7.2) (<a href="./references#CD005055-bbs2-0024" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochraneâhandbook.org. ">Higgins 2011</a>). Now, with the available treatment effect and SE for each outcome of interest, we could enter data into the generic inverse variance model for analysis. We entered dichotomous data presented in the form of an OR as logarithms as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> 5.1.0 (Section 7.7.2) (<a href="./references#CD005055-bbs2-0024" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochraneâhandbook.org. ">Higgins 2011</a>). Because the generic inverse variance model output omits the number of data points contributed by each trial, we have included this information in the 'Additional tables' section of the review (see <a href="#CD005055-tbl-0002">Table 1</a>; <a href="#CD005055-tbl-0003">Table 2</a>; <a href="#CD005055-tbl-0004">Table 3</a>;). We performed the analysis in <a href="./references#CD005055-bbs2-0032" title="RevMan5.2 . Review Manager (RevMan) [Computer program]. Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 5.2</a> (<a href="./references#CD005055-bbs2-0032" title="RevMan5.2 . Review Manager (RevMan) [Computer program]. Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 5.2</a>). </p> <div class="table" id="CD005055-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span>Â <span class="table-title">Individual number of entries for outcome, "Difference in MPAP change score (SE)"</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>iNO (N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Control (N)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Number of entries (N)</p> </div> </div> <div class="table" id="CD005055-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span>Â <span class="table-title">Individual number of entries for outcome,"Difference in MAP change score (SE)"</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>iNO (N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Control (N)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Number of entries (N)</p> </div> </div> <div class="table" id="CD005055-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span>Â <span class="table-title">Individual number of entries for outcome, 'Difference in HR change score (SE)'</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>iNO (N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Control (N)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Number of entries (N)</p> </div> </div> </section> <section id="CD005055-sec-0050"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to do subgroup analysis based on method of control as described above in the <a href="#CD005055-sec-0021">Objectives</a> (placebo or conventional management). </p> <p>We estimated statistical heterogeneity through the Chi<sup>2</sup> test and I<sup>2</sup> statistic. Potential sources of heterogeneity among these studies included differential exposure intensity (for example dosing of iNO and length of treatment), differential treatment of control groups (for example placebo versus conventional management), and host factors (for example age, type of underlying cardiac disease). We planned to explore some of these via subgroup analysis. </p> </section> <section id="CD005055-sec-0051"> <h4 class="title">Sensitivity analysis</h4> <p>We performed sensitivity analyses, when possible, by excluding trials of lower methodologic quality and reanalysing the data. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD005055-sec-0052" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD005055-sec-0052"></div> <section id="CD005055-sec-0053"> <h3 class="title">Description of studies</h3> <p>The details concerning each individual study are addressed in the tables <a href="./references#CD005055-sec-0116" title="">Characteristics of included studies</a> and <a href="./references#CD005055-sec-0117" title="">Characteristics of excluded studies</a>. </p> <section id="CD005055-sec-0054"> <h4 class="title">Results of the search</h4> <p>In our original review we identified six trials that were relevant to our topic of interest (<a href="./references#CD005055-bbs2-0039" title="BizzarroM , GrossI . Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease. Cochrane Database of Systematic Reviews2005, Issue 4. [DOI: 10.1002/14651858.CD005055.pub2] ">Bizzarro 2005</a>). We included four RCTs in the review (<a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>; <a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a>; <a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a>; <a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a>) and excluded two studies (<a href="./references#CD005055-bbs2-0005" title="ArgenzianoM , ChoudhriAF , MoazamiN , RoseEA , SmithCR , LevinHR , et al. Randomized, doubleâblind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. Annals of Thoracic Surgery1998;65(2):340â5. [MEDLINE: PMID: 9485226] ">Argenziano 1998</a>; <a href="./references#CD005055-bbs2-0010" title="MatsuiJ , YahagiN , KumonK , HayashiH , WatanabeY , HarunaM , et al. Effects of inhaled nitric oxide on postoperative pulmonary circulation in patients with congenital heart disease. Artificial Organs1997;21(1):17â20. [MEDLINE: PMID: 9012900] ">Matsui 1997</a>). In our first update (search to November 2007) we identified two relevant studies and excluded both (<a href="./references#CD005055-bbs2-0007" title="KhazinV , KaufmanY , ZabeedaD , MedalionB , SassonL , SchachnerA , et al. Milrinone and nitric oxide: combined effect on pulmonary artery pressures after cardiopulmonary bypass in children. Journal of Cardiothoracic and Vascular Anesthesia2004;18(2):156â9. [MEDLINE: PMID: 15073704] ">Khazin 2004</a>; <a href="./references#CD005055-bbs2-0011" title="SmithHA , CarterJA , ChristianKG , DrinkwaterDC , SchollFG , ChristmanBW , et al. Nitric oxide precursors and congenital heart surgery: a randomized controlled trial of oral citrulline. Journal of Thoracic and Cardiovascular Surgery2006;132(1):58â65. [MEDLINE: PMID: 16798303] ">Smith 2006</a>). For this updated search (from November 2007 to 1 December 2013) we excluded 49 studies considering the inclusion criteria and identified three additional relevant trials (<a href="./references#CD005055-bbs2-0006" title="ChecchiaPA , BronickiRA , MuenzerJT , DixonD , RaithelS , GandhiSK , et al. Nitric oxide delivery during cardiopulmonary bypass reduces postoperative morbidity in childrenââa randomized trial. Journal of Thoracic and Cardiovascular Surgery2013;146(3):530â6. [MEDLINE: 23228403] ">Checchia 2013</a>; <a href="./references#CD005055-bbs2-0008" title="KirbasA , YalcinY , TanrikuluN , GÃ¼rerO , IsikO . Comparison of inhaled nitric oxide and aerosolized iloprost in pulmonary hypertension in children with congenital heart surgery. Cardiology Journal2012;19(4):387â94. [MEDLINE: 22825900] ">Kirbas 2012</a>; <a href="./references#CD005055-bbs2-0009" title="LoukanovT , BucsenezD , SpringerW , SebeningC , RauchH , RoeschE , et al. Comparison of inhaled nitric oxide with aerosolized iloprost for treatment of pulmonary hypertension in children after cardiopulmonary bypass surgery. Clinical Research in Cardiology2011;100(7):595â602. [MEDLINE: PMID: 21318559] ">Loukhanov 2011</a>) but none met out inclusion criteria. For a summary of the search see <a href="#CD005055-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD005055-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD005055-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_n/nCD005055-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD005055-sec-0055"> <h4 class="title">Included studies</h4> <p>Three of the trials were of parallel design (<a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>; <a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a>; <a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a>) while the fourth employed a crossâover design (<a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a>). However, using the recommendations from The Cochrane Collaboration for evaluation of a crossâover trial (<a href="./references#CD005055-bbs2-0012" title="AldersonP , GreenS , editors. Cochrane Collaboration open learning material for reviewers (Version 1.1, November 2002). www.cochraneânet.org/openlearning/HTML/modA2â3.htm. ">Alderson 2002</a>), the authors concluded that the inclusion of this study into the review was valid. The details of the participants and interventions can be found in the table <a href="./references#CD005055-sec-0116" title="">Characteristics of included studies</a>. </p> <p>Each of the four trials included in the review evaluated the use of postoperative iNO in infants and children with CHD necessitating repair. All included participants were identified as having pulmonary hypertension either in the preoperative or postoperative period. In three of the studies (<a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>; <a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a>; <a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a>) postoperative pulmonary hypertension was used as a criterion either for inclusion or for a separate subgroup analysis. One of the RCTs (<a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a>) utilized preoperative diagnosis as part of the entry criteria into the trial but did not comment on the presence or absence of postoperative pulmonary hypertension in individual included participants. </p> <p>In each RCT children were the primary patient population studied. <a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a> included 35 patients aged 2 days to 6.5 years. <a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a> included 44 patients aged 1 day to 20 years (and 2 adults). <a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a> included 12 patients with an age range from 1 month to 17 years (1 adult). <a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a> did not specifically list the age range of their patient population but instead commented on inclusion of 124 patients with a median age of 3 months in the treatment group and 2 months in the control group. We excluded data on adult patients (defined as greater than or equal to 17 years of age) from the analysis. </p> <p>The RCTs differed with respect to the method of treatment utilized in the control groups. <a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a> compared the use of iNO with 'conventional treatment' in the control group. No strict criteria or definition of 'conventional management' were utilized in this trial and management of the control group was instead left to the discretion of the attending cardiothoracic surgeon. <a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a> employed a crossâover method with patients randomized to receive either iNO in the treatment group or hyperventilation as the treatment comparison in the control group (often part of the conventional management protocol). This trial utilized a 30âminute washout period between treatments. With the exception of the intervention, patient management was similar in both groups. <a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a> and <a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a> initiated iNO in the treatment group versus placebo in the control group, although underlying conventional therapies (such as hyperventilation and the use of inotropes) were maintained in both groups. </p> <p>The trials also differed with respect to onset and duration of iNO therapy in the postoperative period. <a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a> initiated iNO or placebo therapy immediately after patients were removed from cardiopulmonary bypass and continued treatment for a total of 20 minutes. <a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a> initiated therapy upon the patient's arrival in the intensive care unit (ICU) and continued treatment until extubation, although data collection occurred at one hour after initiation of therapy. <a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a> used a crossâover study design comparing iNO with hyperventilation. Treatment was initiated at a mean of 8.5 hours postoperation (range 4 to 40 hours) and each treatment was given for a period of 30 minutes. <a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a> initiated therapy just after completion of surgery and continued iNO or placebo for a maximum of seven days. </p> <p>The concentration of iNO utilized also differed among studies. <a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a> initiated iNO at 80 ppm while <a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a> initiated 20 ppm. <a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a> initiated a 5 ppm concentration of iNO for 15 minutes and then 40 ppm for the remaining 15 minutes of treatment (although data were presented only for outcomes on 40 ppm). <a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a> initiated iNO at 10 ppm and continued the use of this concentration throughout the duration of the study. </p> <p>Primary outcomes differed slightly among the RCTs as well. <a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a> and <a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a> compared changes in haemodynamics (MPAP, MAP, HR) as their primary outcomes of interest. <a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a> and <a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a> compared the number of PHTC and the incidence of mortality in each group as their primary outcomes of interest. <a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a> and <a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a> compared changes in haemodynamic measurements as secondary outcomes of interest. </p> <p>Data presentation differed among the RCTs included in this review. <a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a> and <a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a> presented individual data whereas <a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a> and <a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a> presented group data. Individual data were collected from Dr Ronald Day so that certain outcomes of interest, specifically MPAP and MAP, could be calculated and included. With respect to <a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a>, most data were presented as group data in the form of median values and interquartile ranges. We thus assumed that the data were skewed, making it difficult to calculate the necessary means and SDs required for inclusion in the analysis. Attempts to obtain the data from the authors in a form that could be utilized were unsuccessful. </p> </section> <section id="CD005055-sec-0056"> <h4 class="title">Excluded studies</h4> <p>We excluded seven studies during the review process. Of the excluded studies, <a href="./references#CD005055-bbs2-0010" title="MatsuiJ , YahagiN , KumonK , HayashiH , WatanabeY , HarunaM , et al. Effects of inhaled nitric oxide on postoperative pulmonary circulation in patients with congenital heart disease. Artificial Organs1997;21(1):17â20. [MEDLINE: PMID: 9012900] ">Matsui 1997</a> was listed in CENTRAL but was not an RCT; <a href="./references#CD005055-bbs2-0005" title="ArgenzianoM , ChoudhriAF , MoazamiN , RoseEA , SmithCR , LevinHR , et al. Randomized, doubleâblind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. Annals of Thoracic Surgery1998;65(2):340â5. [MEDLINE: PMID: 9485226] ">Argenziano 1998</a> was an RCT on the topic of interest but utilized only an adult patient population; <a href="./references#CD005055-bbs2-0007" title="KhazinV , KaufmanY , ZabeedaD , MedalionB , SassonL , SchachnerA , et al. Milrinone and nitric oxide: combined effect on pulmonary artery pressures after cardiopulmonary bypass in children. Journal of Cardiothoracic and Vascular Anesthesia2004;18(2):156â9. [MEDLINE: PMID: 15073704] ">Khazin 2004</a> compared iNO with milrinone, not placebo or conventional management, and analysed the combined effects of the two agents on pulmonary hypertension in the patient population of interest for this review; <a href="./references#CD005055-bbs2-0011" title="SmithHA , CarterJA , ChristianKG , DrinkwaterDC , SchollFG , ChristmanBW , et al. Nitric oxide precursors and congenital heart surgery: a randomized controlled trial of oral citrulline. Journal of Thoracic and Cardiovascular Surgery2006;132(1):58â65. [MEDLINE: PMID: 16798303] ">Smith 2006</a> compared citrulline, an NO precursor, with placebo in the patient population of interest. <a href="./references#CD005055-bbs2-0009" title="LoukanovT , BucsenezD , SpringerW , SebeningC , RauchH , RoeschE , et al. Comparison of inhaled nitric oxide with aerosolized iloprost for treatment of pulmonary hypertension in children after cardiopulmonary bypass surgery. Clinical Research in Cardiology2011;100(7):595â602. [MEDLINE: PMID: 21318559] ">Loukhanov 2011</a> and <a href="./references#CD005055-bbs2-0008" title="KirbasA , YalcinY , TanrikuluN , GÃ¼rerO , IsikO . Comparison of inhaled nitric oxide and aerosolized iloprost in pulmonary hypertension in children with congenital heart surgery. Cardiology Journal2012;19(4):387â94. [MEDLINE: 22825900] ">Kirbas 2012</a> compared the effects of iNO versus aerosolized iloprost on pulmonary hypertension in the patient population of interest within the first 72 hours postâbypass. <a href="./references#CD005055-bbs2-0006" title="ChecchiaPA , BronickiRA , MuenzerJT , DixonD , RaithelS , GandhiSK , et al. Nitric oxide delivery during cardiopulmonary bypass reduces postoperative morbidity in childrenââa randomized trial. Journal of Thoracic and Cardiovascular Surgery2013;146(3):530â6. [MEDLINE: 23228403] ">Checchia 2013</a> compared the effects of iNO versus placebo delivered to the membrane oxygenator only during cardiopulmonary bypass in children undergoing repair of tetralogy of Fallot. The details of all exclusions can be found in <a href="./references#CD005055-sec-0117" title="">Characteristics of excluded studies</a>. </p> </section> </section> <section id="CD005055-sec-0057"> <h3 class="title">Risk of bias in included studies</h3> <p>We included randomized and quasiârandomized controlled trials in this review (<a href="./references#CD005055-sec-0116" title="">Characteristics of included studies</a>). The bias domains are presented in the 'risk of biasâ summary figure and in the 'risk of biasâ graph (<a href="#CD005055-fig-0002">Figure 2</a> and <a href="#CD005055-fig-0003">Figure 3</a>). Two studies had low risk of bias (<a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>; <a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a>). We assessed methodological quality based on the following criteria. </p> <div class="figure" id="CD005055-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD005055-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_n/nCD005055-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD005055-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD005055-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_n/nCD005055-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD005055-sec-0058"> <h4 class="title">Allocation</h4> <p><a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a> and <a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a> did not list specific techniques for randomization. <a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a> employed a "blind draw from sequential groups containing six assignments". No further detail was given as to who, the investigators or a separate participant, actually performed the draw and assignment. Finally, <a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a> employed a computerâbased randomization program to assign patients to the treatment or control group. </p> <p>Concealment of allocation was adequate in <a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a> and <a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a> as blinding of randomization was likely to have been preserved through the methods of randomization. Concealment was unclear in <a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a> and <a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a> as, since no explicit details about methods of randomization were provided, the review authors had no way of confirming whether or not concealment of allocation was preserved. </p> </section> <section id="CD005055-sec-0059"> <h4 class="title">Blinding</h4> <p><a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a> described adequate blinding of treatment by stating, "The operative team (surgeons, anaesthesiologists, and echocardiographies) were blinded to the treatment assigned". <a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a> also described adequate blinding of treatment as the treatment and placebo gas "were masked with locked opaque covers" and adjusted by a nonâclinical investigator. In the trials by <a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a> and <a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>, however, the investigators were unblinded with respect to treatment, allowing for the possibility of performance bias. Both trials essentially employed iNO versus conventional therapy (hyperventilation in the Morris trial). Without the use of a placebo gas the investigators could not maintain blinding. </p> <p><a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a> and <a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a> were unblinded with respect to outcome assessment, allowing for the introduction of detection bias into their analyses. <a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a> preserved blinded outcome assessment whereas <a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a> did not comment on this level of blinding. </p> <p>We based the overall assessment of methodologic quality primarily on the quality of concealment of allocation. We also factored patient, physician, and outcome assessor blinding into the assessment. Based on this technique for evaluation, we found <a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a> to be of the highest methodologic quality with a low risk of bias. We found <a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a> to be of above average quality with a low to moderate risk of bias. Although concealment of allocation was adequate, a lack of patient, physician, and outcome assessor blinding made the potential for performance and detection bias likely. We assessed <a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a> to be of average methodologic quality due to lack of concealment of allocation. We determined <a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a> to be of poor methodologic quality, particularly for the lack of concealed allocation and blinding. We attempted to assess the trials of higher quality (for example <a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a> and <a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>) separately in a sensitivity analysis but could not do so due to sample size. These issues of methodologic quality are addressed in further detail in the <a href="#CD005055-sec-0090">Discussion</a> section below. </p> </section> <section id="CD005055-sec-0060"> <h4 class="title">Incomplete outcome data</h4> <p><a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a> initially randomized 39 patients but only obtained results from 35 patients as four were excluded due to technical problems (three for failure to place a necessary pulmonary artery catheter and one due to equipment problems). Which group these patients were initially assigned to was not described. <a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a> enrolled 44 patients (two patients were actually enrolled on two separate occasions for separate surgical procedures) and followed all to completion of the study. Four patients initially assigned to the control group were allowed to cross over and receive iNO if conventional therapy failed. These were excluded from the analysis. <a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a> enrolled 12 patients and followed all to completion. <a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a> initially enrolled 124 infants, all of whom completed the study. Intention to treat was preserved in all trials. </p> </section> <section id="CD005055-sec-0061"> <h4 class="title">Selective reporting</h4> <p>All trials reported all expected outcomes. There was no risk of bias identified in any of the studies. </p> </section> <section id="CD005055-sec-0062"> <h4 class="title">Other potential sources of bias</h4> <p>Two studies appeared to be free of other sources of bias (<a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a>; <a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a>). <a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a> did not analyse patients with initial low pulmonary arterial pressure and excluded patients who developed an increase in pressure after they were already excluded from the study. <a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a> did not measure the methaemoglobin level in all patients who received iNO. </p> </section> </section> <section id="CD005055-sec-0063"> <h3 class="title" id="CD005055-sec-0063">Effects of interventions</h3> <p>See: <a href="./full#CD005055-tbl-0001"><b>Summary of findings for the main comparison</b> Inhaled nitric oxide compared to placebo or conventional therapy for all infants and children with congenital heart disease having postoperative management of pulmonary hypertension</a> </p> <p>See: <a href="./full#CD005055-tbl-0001">summary of findings Table for the main comparison</a> for the main comparison. </p> <section id="CD005055-sec-0064"> <h4 class="title">Inhaled nitric oxide versus placebo or conventional treatment, or both</h4> <p>No data were available on several outcomes that we had hoped to include in our analysis. In particular, no longâterm followâup data were available from any of the four trials and thus we could not assess the outcomes of longâterm mortality and neurodevelopmental disability. In addition, no data on length of hospital stay were available for analysis from any of the trials. </p> <section id="CD005055-sec-0065"> <h5 class="title">Longâterm mortality</h5> <p>No data were available for this outcome from any of the trials included in this review.</p> </section> <section id="CD005055-sec-0066"> <h5 class="title">Mortality prior to discharge</h5> <p>Mortality was reported in two of the four trials included in this review (<a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>; <a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a>). <a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a> reported no deaths in either the treatment or control group whereas <a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a> observed five deaths out of the 63 children in the treatment group and three of 61 in the control group (although only one death in each group was believed to be related to a PHTC). The data presented were from parallel trials only and, therefore, we decided to calculate an OR. The analysis showed no statistically significant difference with respect to mortality between the two groups (OR 1.67, 95% CI 0.38 to 7.30; P = 0.50) (<a href="./references#CD005055-fig-0005" title="">Analysis 1.1</a>; <a href="#CD005055-fig-0004">Figure 4</a>). </p> <div class="figure" id="CD005055-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Inhaled nitric oxide versus placebo or conventional management, outcome: 1.1 Mortality prior to discharge." data-id="CD005055-fig-0004" src="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_n/nCD005055-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Inhaled nitric oxide versus placebo or conventional management, outcome: 1.1 Mortality prior to discharge. </p> </div> </div> </div> </section> <section id="CD005055-sec-0067"> <h5 class="title">Length of stay in intensive care unit or hospital</h5> <p>No data were available for this outcome from any of the trials included in the review.</p> </section> <section id="CD005055-sec-0068"> <h5 class="title">Incidence and severity of neurodevelopmental disability</h5> <p>No data were available for this outcome from any of the trials included in this review.</p> </section> <section id="CD005055-sec-0069"> <h5 class="title">Mean number of pulmonary hypertensive crises (PHTC)</h5> <p>This outcome was reported only in <a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a> with 3 PHTC out of the 18 children in the treatment group and 4 PHTC out of the 20 children in the control group. The data were from a parallel trial and we calculated an OR. The analysis showed no significant difference with respect to the absolute number of PHTC in the treatment versus the control groups (OR 0.80, 95% CI 0.15 to 4.18; P = 0.79) (<a href="./references#CD005055-fig-0006" title="">Analysis 1.2</a>). </p> </section> <section id="CD005055-sec-0070"> <h5 class="title">Difference in mean pulmonary arterial pressure (MPAP) change score</h5> <p>This outcome was initially reported in two of the four trials (<a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a>; <a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a>) and recorded, but not reported, in a third (<a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>). As a result, we obtained and analysed the raw, individual patient data from the investigators. A reduction in MPAP was considered a favourable outcome. </p> <p>Overall, the metaâanalysis revealed no significant change in MPAP between iNO and control (treatment effect â2.94 mm Hg, 95% CI â9.28 to 3.40; P = 0.36). The level of heterogeneity (I<sup>2</sup> = 45%) was just below that considered significant (<a href="./references#CD005055-fig-0007" title="">Analysis 1.3</a>). </p> </section> <section id="CD005055-sec-0071"> <h5 class="title">Difference in mean arterial pressure (MAP) change score</h5> <p>This outcome was reported in three of the included trials (<a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>; <a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a>; <a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a>). A reduction in MAP was considered an unfavourable outcome whereas no change or an increase in MAP from baseline was considered favourable. </p> <p>Overall, the metaâanalysis revealed no significant difference in effect between the two groups (treatment effect â3.55 mm Hg, 95% CI â11.86 to 4.76; P = 0.40). We observed no heterogeneity (I<sup>2</sup> = 0%) between trials (<a href="./references#CD005055-fig-0008" title="">Analysis 1.4</a>). </p> </section> <section id="CD005055-sec-0072"> <h5 class="title">Difference in heart rate (HR) change score</h5> <p>This outcome was reported in three of the four trials (<a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>; <a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a>; <a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a>). A reduction in HR, assuming constant stroke volume, was considered an unfavourable outcome as compared to no change or an increase from baseline. </p> <p>Overall, the metaâanalysis did not show a significant difference in overall effect in either group (treatment effect 0.02 bpm, 95% CI â8.13 to 8.18; P = 1.00). We observed no heterogeneity between studies (I<sup>2</sup> = 0%) (<a href="./references#CD005055-fig-0009" title="">Analysis 1.5</a>). </p> </section> <section id="CD005055-sec-0073"> <h5 class="title">Difference in PaO<sub>2</sub>:FiO<sub>2</sub> change score </h5> <p>Only one parallel trial (<a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>) included this outcome. An increase in this ratio was considered a favourable outcome and indicative of improved arterial oxygenation. The trial observed no significant change in the ratio with the use of iNO as compared with control (MD 17.18, 95% CI â28.21 to 62.57; P = 0.46) (<a href="./references#CD005055-fig-0010" title="">Analysis 1.6</a>). </p> </section> <section id="CD005055-sec-0074"> <h5 class="title">Maximum methaemoglobin level</h5> <p>This outcome was reported in only one of the four studies (<a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>). An increase in methaemoglobin level was considered an unfavourable outcome. These data were from a parallel trial and thus we calculated a weighted mean difference. Overall, there was a significantly elevated methaemoglobin level in the iNO group when compared to control (MD 0.30%, 95% CI 0.24 to 0.36; P &lt; 0.00001). However, the maximum methaemoglobin level did not approach toxicity levels (&gt; 10%) (<a href="./references#CD005055-fig-0011" title="">Analysis 1.7</a>). </p> </section> </section> <section id="CD005055-sec-0075"> <h4 class="title">Subgroup analyses</h4> </section> <section id="CD005055-sec-0076"> <h4 class="title">Inhaled nitric oxide versus conventional management</h4> <p>This analysis utilized data from <a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a> and <a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a>. These investigators compared the use of iNO to conventional therapies in the management of postoperative pulmonary hypertension. </p> <section id="CD005055-sec-0077"> <h5 class="title">Mortality prior to discharge</h5> <p>Data from <a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a> revealed no deaths in either treatment or control groups and so no analysis was performed. </p> </section> <section id="CD005055-sec-0078"> <h5 class="title">Mean number of pulmonary hypertensive crises (PHTC)</h5> <p>The analysis revealed no significant difference in the number of PHTC experienced by the treatment and control groups (the same data as that presented in <a href="./references#CD005055-fig-0006" title="">Analysis 1.2</a>). </p> </section> <section id="CD005055-sec-0079"> <h5 class="title">Difference in MPAP change score</h5> <p>This analysis included data from <a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a> and <a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a>. We observed no statistically significant change in MPAP (treatment effect â1.14 mm Hg, 95% CI â8.87 to 6.59; P = 0.77) and a significant amount of heterogeneity between studies (I<sup>2</sup> = 58%) (<a href="./references#CD005055-fig-0007" title="">Analysis 1.3</a>). </p> </section> <section id="CD005055-sec-0080"> <h5 class="title">Difference in MAP change score</h5> <p>The data analysis revealed no significant difference in the change in MAP between treatment and control groups (treatment effect â1.94 mm Hg, 95% CI â11.23 to 7.35; P = 0.68). We observed no heterogeneity between studies on this outcome (<a href="./references#CD005055-fig-0008" title="">Analysis 1.4</a>). </p> </section> <section id="CD005055-sec-0081"> <h5 class="title">Difference in HR change score</h5> <p>This analysis was again comprised of data from <a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a> and <a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a>. There was no significant difference observed in the change in HR between groups (treatment effect â0.37 bpm, 95% CI â8.85 to 8.10; P = 0.93). No heterogeneity was observed (<a href="./references#CD005055-fig-0009" title="">Analysis 1.5</a>). </p> </section> <section id="CD005055-sec-0082"> <h5 class="title">Difference in PaO<sub>2</sub>:FiO<sub>2</sub> change score </h5> <p>This outcome included data only from <a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>, which was the same data as presented in <a href="./references#CD005055-fig-0010" title="">Analysis 1.6</a><i>.</i> </p> </section> <section id="CD005055-sec-0083"> <h5 class="title">Maximum methaemoglobin level</h5> <p>This outcome was reported in only one study (<a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>), which was the same data as presented in <a href="./references#CD005055-fig-0011" title="">Analysis 1.7</a>. </p> </section> </section> <section id="CD005055-sec-0084"> <h4 class="title">Inhaled nitric oxide versus placebo</h4> <p>This analysis separated those trials utilizing placebo in the control group from those which initiated conventional therapy (that is hyperventilation, pressor support, etc). We included <a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a> and <a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a>. </p> <section id="CD005055-sec-0085"> <h5 class="title">Mortality prior to discharge</h5> <p><a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a> reported on this outcome. Since the only other trial (<a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>) that also reported mortality had no events the results were the same as previously described (<a href="./references#CD005055-fig-0005" title="">Analysis 1.1</a>). </p> </section> <section id="CD005055-sec-0086"> <h5 class="title">Difference in MPAP change score</h5> <p>We utilized data from <a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a> in this analysis and observed no significant change in MPAP in the treatment group compared with placebo (treatment effect â9.15 mm Hg, 95% CI â20.70 to 2.40; P = 0.12) (<a href="./references#CD005055-fig-0007" title="">Analysis 1.3</a>). </p> </section> <section id="CD005055-sec-0087"> <h5 class="title">Difference in MAP change score</h5> <p>We utilized data from <a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a> in this analysis and observed no significant change in MAP with the use of iNO (treatment effect â10.00 mm Hg, 95% CI â28.60 to 8.60; P = 0.29) (<a href="./references#CD005055-fig-0008" title="">Analysis 1.4</a>). </p> </section> <section id="CD005055-sec-0088"> <h5 class="title">Difference in HR change score</h5> <p>We utilized data from <a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a> in this analysis. We observed no significant difference between the treatment and control groups with respect to change in HR (treatment effect 5.00 bpm, 95% CI â24.99 to 34.99; P = 0.74) (<a href="./references#CD005055-fig-0009" title="">Analysis 1.5</a>). </p> </section> </section> <section id="CD005055-sec-0089"> <h4 class="title">Sensitivity analysis</h4> <p>We considered <a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a> and <a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a> to be of highest methodologic quality. <a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a> only reported on the outcome mortality prior to discharge. This was the same data as presented in <a href="./references#CD005055-fig-0005" title="">Analysis 1.1</a>, which showed no significant difference between groups (P = 0.50). No other sensitivity analyses could be performed. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD005055-sec-0090" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD005055-sec-0090"></div> <section id="CD005055-sec-0091"> <h3 class="title" id="CD005055-sec-0091">Summary of main results</h3> <p>A substantial amount of data have been published favouring the use of iNO in the treatment of neonates with persistent pulmonary hypertension (<a href="./references#CD005055-bbs2-0016" title="ClarkRH , KueserTJ , WalkerMW , SouthgateWM , HuckabyJL , PerezJA , et al. Lowâdose nitric oxide therapy for persistent pulmonary hypertension of the newborn. New England Journal of Medicine2000;342(7):469â74. [MEDLINE: 10675427] ">Clark 2000</a>; <a href="./references#CD005055-bbs2-0027" title="KinsellaJP , NeishSR , ShafferE , AbmanSH . Lowâdose inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet1992;340(8823):819â20. [MEDLINE: 1357246] ">Kinsella 1992</a>; <a href="./references#CD005055-bbs2-0031" title="Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in fullâterm and nearly fullâterm infants with hypoxic respiratory failure. New England Journal of Medicine1997;336(9):597â604. [MEDLINE: 9036320] ">NINOS 1997</a>; <a href="./references#CD005055-bbs2-0033" title="RobertsJD , PolanerDM , LangP . Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet1992;340(8823):818â9. [MEDLINE: 1357245] ">Roberts 1992</a>; <a href="./references#CD005055-bbs2-0034" title="RobertsJD , FinemanJR , MorinFC , ShawlPW , RimarS , SchreiberMD , et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. New England Journal of Medicine1997;336(9):605â10. [MEDLINE: 9032045] ">Roberts 1997</a>). These findings have encouraged research in other patient populations demonstrating pulmonary hypertension. In children with CHD, elevated pulmonary arterial pressures may complicate postoperative recovery and, in some instances, potentiate lifeâthreatening crises. As a result, safe and effective therapeutic intervention has been sought. This review evaluated the therapeutic role of iNO in the postoperative management of infants and children with CHD. </p> <p>The four RCTs included in this review focused on two major types of primary objectives. <a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a> and <a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a> evaluated the postoperative effect of iNO on shortâterm clinical outcomes (for example mortality, number of lifeâthreatening crises, improvements in oxygenation), while <a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a> and <a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a> evaluated the physiologic changes (for example MPAP, MAP, HR) that occur with the use of iNO. Unfortunately, no data were collected to evaluate the longâterm outcomes of morbidity (for example neurodevelopmental disability) and mortality. </p> <p>In analysing the primary outcome of mortality prior to discharge, we observed no statistically significant difference between the treatment and control groups. These findings are based on data from two trials (<a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>; <a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a>), one of which (<a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>) observed no deaths in either group studied. While these findings indicate no substantial difference in mortality between those children treated with iNO and those treated with placebo or conventional therapy, the relatively small sample size (N = 162) and low incidence of PHTCârelated postoperative deaths (N = 2) must be considered when attempting to draw general conclusions. A similar problem arises in the analysis of secondary outcomes. While no differences were observed between treatment and control groups with respect to the number of PHTC in the postoperative period, the data are based on one RCT (<a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>). </p> <p><a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a> and <a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a> focused on changes in haemodynamics in the postoperative period. <a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a> and <a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a> also documented these changes but as secondary outcomes. As a selective pulmonary vasodilator, one might expect iNO to cause a significant decrease in MPAP when compared with placebo. When we examined this outcome we observed no statistically significant change in MPAP with the use of iNO versus control. Similarly, no significant differences were observed between groups with respect to changes in MAP or HR. Subgroup analysis by method of control also demonstrated no significant differences in haemodynamics with either method of control, but valid interpretation of these findings was difficult based on the small numbers of patients analysed in each group. </p> <p>The ratio PaO<sub>2</sub>:FiO<sub>2</sub> is a measure of oxygenation and a positive change in this ratio implies an improvement. This outcome was measured in only one trial (<a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>) and revealed no significant difference between treatment and control groups. It is unclear whether this lack of improvement is related to ineffectiveness of iNO to promote increased pulmonary blood flow. </p> <p>The maximum methaemoglobin level, a measure of toxicity, was reported only in <a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>. In the analysis there was a significant increase in this measure in the iNO group as compared to the control group, which one would expect as methaemoglobin, a byproduct of iNO, should not be elevated in the control group. What is more important is whether or not the maximum level approached toxicity (&gt; 10%), which it did not. </p> <p>Thus, from this analysis it appears that the postoperative use of iNO does not result in a significant reduction in mortality and the number of PHTC, nor does its use appear to significantly alter haemodynamics or result in any improvement in other clinically relevant outcomes such as arterial oxygenation. However, the validity of these conclusions needs to be examined further. </p> <p>The major limitation of this review relates to sample size which, when data were available, affected both the precision and interpretability of the results. When assessing one of our primary outcomes, mortality prior to discharge, data were available from only two trials (<a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>; <a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a>) with only two deaths observed. Similarly, when assessing the number of PHTC, data were only available from one trial (<a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>). Furthermore, data on longâterm mortality, neurodevelopmental disability, and length of stay were simply not available. In addition, there was significant potential for selection bias in two of the four trials (<a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a>; <a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a>) and heterogeneity between studies given that all trials utilized different concentrations of inhaled nitric oxide, different lengths of administration of therapy, and included patients with diverse congenital heart lesions and of various ages. </p> <p>The strengths of the review were that it included four RCTs. Also, we were able to obtain data on the majority of our outcomes of interest, which included individual patient data in most cases. Lastly, while there was concern about heterogeneity, no significant heterogeneity was observed between studies when analysing the majority of outcomes of interest. </p> </section> <section id="CD005055-sec-0092"> <h3 class="title" id="CD005055-sec-0092">Overall completeness and applicability of evidence</h3> <p>Several factors exist within and amongst the included trials that make an accurate metaâanalysis with a definitive conclusion difficult. The first area of concern to be addressed is with respect to the methodologic quality of the included studies. The trial of highest methodologic quality (<a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a>) only included data with respect to mortality that could be included in the analysis. Of the three remaining trials, we assessed only one (<a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>) as being of relatively high methodologic quality based on concealment of allocation. Thus, the potential for selection bias is likely in the remaining two trials (<a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a>; <a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a>). Although the results of this metaâanalysis do not appear to show any significant clinical benefit of iNO to treat pulmonary hypertension in children with CHD, any significant clinical harm is not identified in this systematic review. </p> </section> <section id="CD005055-sec-0093"> <h3 class="title" id="CD005055-sec-0093">Quality of the evidence</h3> <p>We considered the quality of the evidence using the measurement of risk of bias. There was one study that had a low risk of bias in all domains (<a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a>). Random sequence generation, allocation concealment, incomplete outcome data, and selective reporting were not assessed as high risk of bias in all included studies. Small sample sizes affected precision of the results. There was not substantial heterogeneity between the studies that analysed the majority of outcomes of interest. </p> </section> <section id="CD005055-sec-0094"> <h3 class="title" id="CD005055-sec-0094">Potential biases in the review process</h3> <p>Factors that also contribute to potential biases are lack of blinding to the intervention (<a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>; <a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a>) and lack of blinded outcome assessment, or failure to report this procedure, in all three studies. Therefore, the potential for the introduction of bias into the trials and subsequently the analysis is likely. We attempted to address this issue via sensitivity analysis, by evaluating only those trials of high methodologic quality (<a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>; <a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a>). Unfortunately the only outcome that could be assessed, given the lack of individual data from one trial (<a href="./references#CD005055-bbs2-0002" title="MillerOI , TangSF , KeechA , PigottNB , BellerE , CelermajerDS . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleâblind study. Lancet2000;356(9240):1464â9. [MEDLINE: PMID: 11081528] ">Miller 2000</a>), was mortality prior to discharge. </p> <p>Also of concern is the relatively sparse number of patients included in the majority of the studies, as documented in the 'Additional tables' section of this review (see <a href="#CD005055-tbl-0002">Table 1</a>; <a href="#CD005055-tbl-0003">Table 2</a>; <a href="#CD005055-tbl-0004">Table 3</a>). A total of 73 outcomes collected from 62 infants and children (iNO group = 34, placebo and conventional management groups = 39) were included (the discrepancy arises as a result of the crossâover design of <a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a>). A possible explanation for the relatively small numbers of participants lies in the fact that we are dealing with a very specific population with CHD necessitating repair and demonstrating elevated pulmonary arterial pressures. The small sample sizes are reflected in the wide CIs seen in the analysis and, as a result, compromise the precision of the review. </p> <p>Another serious problem with the metaâanalysis concerns the potential heterogeneity that exists among the included investigations. All four trials utilized different concentrations of iNO, different lengths of administration of therapy, and included patients with diverse congenital heart lesions and of various ages. While the I<sup>2</sup> statistic for heterogeneity is not statistically significant in most cases, the potential is apparent. An attempt to deal with this is presented in the form of the subgroup analysis on method of control. Unfortunately, further subgroup analyses based on host factors and concentration of iNO administered could not be performed due to small sample sizes and missing individual patient data. Therefore, although no significant differences were observed with the use of iNO in this patient population, there is the potential for heterogeneity and bias that compromise the results of the review and make it impossible to draw any definitive conclusions at the present time. </p> </section> <section id="CD005055-sec-0095"> <h3 class="title" id="CD005055-sec-0095">Agreements and disagreements with other studies or reviews</h3> <p>A Cochrane systematic review considered inhaled nitric oxide for respiratory failure in infants born at or near term (<a href="./references#CD005055-bbs2-0021" title="FinerN , BarringtonKJ . Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database of Systematic Reviews2006, Issue 11. [DOI: 10.1002/14651858.CD000399] ">Finer 2009</a>). The authors found a statistically significant reduction in death or need for extracorporeal membrane oxygenation (ECMO) with the use of iNO (MantelâHanzel risk ratio 0.65, 95% CI 0.55 to 0.76). This paper did not include studies from our review as it focused on infants with acute respiratory disease, not postoperative patients with CHD, and assessed different outcomes of interest including the need for ECMO. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD005055-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/urn:x-wiley:14651858:media:CD005055:CD005055-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_t/tCD005055-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD005055-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_n/nCD005055-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/full#CD005055-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_n/nCD005055-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005055-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/urn:x-wiley:14651858:media:CD005055:CD005055-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_t/tCD005055-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD005055-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_n/nCD005055-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/full#CD005055-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_n/nCD005055-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005055-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/urn:x-wiley:14651858:media:CD005055:CD005055-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_t/tCD005055-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD005055-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_n/nCD005055-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/full#CD005055-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_n/nCD005055-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005055-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/urn:x-wiley:14651858:media:CD005055:CD005055-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_t/tCD005055-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Inhaled nitric oxide versus placebo or conventional management, outcome: 1.1 Mortality prior to discharge." data-id="CD005055-fig-0004" src="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_n/nCD005055-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Inhaled nitric oxide versus placebo or conventional management, outcome: 1.1 Mortality prior to discharge. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/full#CD005055-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_n/nCD005055-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005055-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/urn:x-wiley:14651858:media:CD005055:CD005055-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_t/tCD005055-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhaled nitric oxide versus placebo or conventional management, Outcome 1 Mortality prior to discharge." data-id="CD005055-fig-0005" src="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_n/nCD005055-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Inhaled nitric oxide versus placebo or conventional management, Outcome 1 Mortality prior to discharge. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/references#CD005055-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_n/nCD005055-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005055-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/urn:x-wiley:14651858:media:CD005055:CD005055-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_t/tCD005055-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhaled nitric oxide versus placebo or conventional management, Outcome 2 Pulmonary hypertensive crises." data-id="CD005055-fig-0006" src="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_n/nCD005055-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Inhaled nitric oxide versus placebo or conventional management, Outcome 2 Pulmonary hypertensive crises. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/references#CD005055-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_n/nCD005055-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005055-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/urn:x-wiley:14651858:media:CD005055:CD005055-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_t/tCD005055-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhaled nitric oxide versus placebo or conventional management, Outcome 3 Difference in MPAP change score (SE)." data-id="CD005055-fig-0007" src="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_n/nCD005055-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Inhaled nitric oxide versus placebo or conventional management, Outcome 3 Difference in MPAP change score (SE). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/references#CD005055-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_n/nCD005055-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005055-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/urn:x-wiley:14651858:media:CD005055:CD005055-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_t/tCD005055-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhaled nitric oxide versus placebo or conventional management, Outcome 4 Difference in MAP change score (SE)." data-id="CD005055-fig-0008" src="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_n/nCD005055-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Inhaled nitric oxide versus placebo or conventional management, Outcome 4 Difference in MAP change score (SE). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/references#CD005055-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_n/nCD005055-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005055-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/urn:x-wiley:14651858:media:CD005055:CD005055-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_t/tCD005055-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhaled nitric oxide versus placebo or conventional management, Outcome 5 Difference in HR change score (SE)." data-id="CD005055-fig-0009" src="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_n/nCD005055-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Inhaled nitric oxide versus placebo or conventional management, Outcome 5 Difference in HR change score (SE). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/references#CD005055-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_n/nCD005055-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005055-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/urn:x-wiley:14651858:media:CD005055:CD005055-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_t/tCD005055-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhaled nitric oxide versus placebo or conventional management, Outcome 6 Difference in PaO2:FiO2 change score." data-id="CD005055-fig-0010" src="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_n/nCD005055-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Inhaled nitric oxide versus placebo or conventional management, Outcome 6 Difference in PaO2:FiO2 change score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/references#CD005055-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_n/nCD005055-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005055-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/urn:x-wiley:14651858:media:CD005055:CD005055-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_t/tCD005055-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhaled nitric oxide versus placebo or conventional management, Outcome 7 Maximum methaemoglobin level." data-id="CD005055-fig-0011" src="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_n/nCD005055-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Inhaled nitric oxide versus placebo or conventional management, Outcome 7 Maximum methaemoglobin level. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/references#CD005055-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/media/CDSR/CD005055/image_n/nCD005055-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD005055-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span>Â <span class="table-title">Inhaled nitric oxide compared to placebo or conventional therapy for all infants and children with congenital heart disease having postoperative management of pulmonary hypertension</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Inhaled nitric oxide compared to placebo or conventional therapy for all infants and children with congenital heart disease having postoperative management of pulmonary hypertension</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> all infants and children with congenital heart disease having postoperative management of pulmonary hypertension<br/> <b>Settings:</b> postoperative<br/> <b>Intervention:</b> inhaled nitric oxide<br/> <b>Comparison:</b> placebo or conventional therapy </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Placebo or conventional therapy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Inhaled nitric oxide</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Longâterm mortality</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>0<br/> (0) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>No studies met outcome definition</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Mortality prior to discharge</b><sup>1</sup> <br/> Followâup: mean 15 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 1.67</b> <br/> (0.38 to 7.3) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>162<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>ââââ<br/> <b>very low</b><sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>37 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>60 per 1000</b> <br/> (14 to 219) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>41 per 1000</b> <br/> (10 to 158) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Difference in MPAP change score (SE) â Conventional Management</b><sup>4</sup> <br/> Followâup: mean 5 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/> <b>very low</b><sup>4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â1.14 (â8.87 to 6.59)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Difference in MPAP change score (SE) â Placebo</b><sup>4</sup> <br/> Followâup: mean 5 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable<sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/> <b>very low</b><sup>6,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â9.15 (â20.7 to 2.4)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Difference in MAP change score (SE) â Conventional Mangement</b><sup>4</sup> <br/> Followâup: mean 5 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/> <b>very low</b><sup>4,5,8</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â1.94 (â11.23 to 7.35)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Difference in MAP change score (SE) â Placebo</b><sup>4</sup> <br/> Followâup: mean 5 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable<sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/> <b>very low</b><sup>6,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â10 (â28.6 to 8.6)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> One of the two trials had zero events (<a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>).<br/> <sup>2</sup> Statistical heterogeneity could not be measured. One of the two trials had zero events (<a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>).<br/> <sup>3</sup> There was very low precision because of the small numbers and the low rate of events (only 162 patients and 8 events). One of the two trials had zero events (<a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>).<br/> <sup>4</sup> Preâspecified subgroup analysis.<br/> <sup>5</sup> One of the two trials included was assessed as having a low risk of bias (<a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a>).<br/> <sup>6</sup> Preâspecified subgroup analysis. Study was assessed as having high risk of bias (<a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a>).<br/> <sup>7</sup> Statistical heterogeneity could not be measured.<br/> <sup>8</sup> There was very low precision because of the small numbers (only 50 patients). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span>Â <span class="table-title">Inhaled nitric oxide compared to placebo or conventional therapy for all infants and children with congenital heart disease having postoperative management of pulmonary hypertension</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/full#CD005055-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD005055-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span>Â <span class="table-title">Individual number of entries for outcome, "Difference in MPAP change score (SE)"</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>iNO (N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Control (N)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p>Number of entries (N)</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span>Â <span class="table-title">Individual number of entries for outcome, "Difference in MPAP change score (SE)"</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/full#CD005055-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD005055-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span>Â <span class="table-title">Individual number of entries for outcome,"Difference in MAP change score (SE)"</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>iNO (N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Control (N)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p>Number of entries (N)</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span>Â <span class="table-title">Individual number of entries for outcome,"Difference in MAP change score (SE)"</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/full#CD005055-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD005055-tbl-0004"> <div class="table-heading"><span class="table-label">Table 3.</span>Â <span class="table-title">Individual number of entries for outcome, 'Difference in HR change score (SE)'</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>iNO (N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Control (N)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005055-bbs2-0004" title="RussellIA , ZwassMS , FinemanJR , BaleaM , RouineâRappK , BrookM , et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia1998;87(1):46â51. ">Russell 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005055-bbs2-0001" title="DayRW , HawkinsJA , McGoughEC , CrezeeKL , OrsmondGS . Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery2000;69(6):1907â13. [MEDLINE: PMID: 10892945] ">Day 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005055-bbs2-0003" title="MorrisK , BeghettiM , PetrosA , AdatiaI , BohnD . Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine2000;28(8):2974â8. [MEDLINE: PMID: 10966281] ">Morris 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p>Number of entries (N)</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span>Â <span class="table-title">Individual number of entries for outcome, 'Difference in HR change score (SE)'</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/full#CD005055-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005055-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 1.</span>Â <span class="table-title">Inhaled nitric oxide versus placebo or conventional management</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality prior to discharge <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (MâH, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.67 [0.38, 7.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Pulmonary hypertensive crises <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (MâH, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.8 [0.15, 4.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Difference in MPAP change score (SE) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Change in MPAP (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â2.94 [â9.28, 3.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Conventional Management</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Change in MPAP (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â1.14 [â8.87, 6.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Change in MPAP (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â9.15 [â20.70, 2.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Difference in MAP change score (SE) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Change in MAP (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â3.55 [â11.86, 4.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Conventional Mangement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Change in MAP (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â1.94 [â11.23, 7.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Change in MAP (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â10.0 [â28.60, 8.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Difference in HR change score (SE) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Change in HR (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [â8.13, 8.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Conventional Management</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Change in HR (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â0.37 [â8.85, 8.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Change in HR (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.0 [â24.99, 34.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Difference in PaO2:FiO2 change score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>17.18 [â28.21, 62.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Maximum methaemoglobin level <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.24, 0.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span>Â <span class="table-title">Inhaled nitric oxide versus placebo or conventional management</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005055.pub3/references#CD005055-tbl-0005">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD005055.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD005055-note-0002">EspaÃ±ol</a> </li> <li class="section-language"> <a class="" href="fa#CD005055-note-0008">ÙØ§Ø±Ø³Û</a> </li> <li class="section-language"> <a class="" href="ms#CD005055-note-0001">Bahasa Malaysia</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright Â© 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">Â Â Facebook</a> <a class="a2a_button_x share-button">Â Â X(Twitter)</a> <a class="a2a_button_whatsapp share-button">Â Â WhatsApp</a> <a class="a2a_dd share-button">Â Â View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005055\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005055\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005055\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005055\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005055\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005055\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005055\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005055\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005055\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005055\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005055\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005055\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005055\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005055\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005055\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005055\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005055\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005055\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jiwTpTuf&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005055.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005055.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">EspaÃ±ol</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">ÙØ§Ø±Ø³Û</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">FranÃ§ais</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">à¤¹à¤¿à¤¨à¥à¤¦à¥</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">æ¥æ¬èª</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">íêµ­ì´</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">PortuguÃªs</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Ð ÑÑÑÐºÐ¸Ð¹</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">RomÃ¢nÄ</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">à®¤à®®à®¿à®´à¯</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">à¸ à¸²à¸©à¸²à¹à¸à¸¢</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">ç¹é«ä¸­æ</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">ç®ä½ä¸­æ</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD005055.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD005055.pub3/full/es">EspaÃ±ol</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005055.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740725354079"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005055.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740725354083"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005055.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e792eb8dc936e',t:'MTc0MDcyNTM1NC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 